- Home
- TWIN vs ACOG Comparison
TWIN vs ACOG Comparison
Compare TWIN & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWIN
- ACOG
- Stock Information
- Founded
- TWIN 1918
- ACOG 2000
- Country
- TWIN United States
- ACOG Canada
- Employees
- TWIN N/A
- ACOG N/A
- Industry
- TWIN Industrial Machinery/Components
- ACOG
- Sector
- TWIN Industrials
- ACOG
- Exchange
- TWIN Nasdaq
- ACOG Nasdaq
- Market Cap
- TWIN 97.0M
- ACOG 80.3M
- IPO Year
- TWIN N/A
- ACOG N/A
- Fundamental
- Price
- TWIN $7.38
- ACOG $9.85
- Analyst Decision
- TWIN Strong Buy
- ACOG Strong Buy
- Analyst Count
- TWIN 1
- ACOG 1
- Target Price
- TWIN $12.00
- ACOG $20.00
- AVG Volume (30 Days)
- TWIN 49.6K
- ACOG 199.2K
- Earning Date
- TWIN 05-07-2025
- ACOG 05-15-2025
- Dividend Yield
- TWIN 2.20%
- ACOG N/A
- EPS Growth
- TWIN N/A
- ACOG N/A
- EPS
- TWIN 0.29
- ACOG N/A
- Revenue
- TWIN $328,478,000.00
- ACOG $2,928,654.00
- Revenue This Year
- TWIN $27.91
- ACOG N/A
- Revenue Next Year
- TWIN N/A
- ACOG N/A
- P/E Ratio
- TWIN $24.89
- ACOG N/A
- Revenue Growth
- TWIN 11.49
- ACOG N/A
- 52 Week Low
- TWIN $6.16
- ACOG $3.75
- 52 Week High
- TWIN $14.98
- ACOG $11.40
- Technical
- Relative Strength Index (RSI)
- TWIN 51.53
- ACOG N/A
- Support Level
- TWIN $6.90
- ACOG N/A
- Resistance Level
- TWIN $7.44
- ACOG N/A
- Average True Range (ATR)
- TWIN 0.35
- ACOG 0.00
- MACD
- TWIN 0.01
- ACOG 0.00
- Stochastic Oscillator
- TWIN 54.55
- ACOG 0.00
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About ACOG Alpha Cognition Inc. Common Stock
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.